ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

Taispeáin leaganacha eile (1)

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	R.T. Saygitov
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	"Paediatrician" Publishers LLC 2008-08-01
Sraith:	Вопросы современной педиатрии
Rochtain ar líne:	https://vsp.spr-journal.ru/jour/article/view/1441

Míreanna comhchosúla

ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
de réir: Cardile S, et al.
Foilsithe / Cruthaithe: (2012-02-01)

Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
de réir: Yu. V. Yevsyutina
Foilsithe / Cruthaithe: (2018-08-01)

Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
de réir: Gold Benjamin D, et al.
Foilsithe / Cruthaithe: (2009-11-01)

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
de réir: Roy C Orlando, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
de réir: Tang RS, et al.
Foilsithe / Cruthaithe: (2013-10-01)

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
de réir: Nima Arezoomandi, et al.
Foilsithe / Cruthaithe: (2019-02-01)

The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
de réir: El-Dika Samer, et al.
Foilsithe / Cruthaithe: (2005-01-01)

Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy
de réir: Adel Salah Bediwy, et al.
Foilsithe / Cruthaithe: (2011-01-01)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
de réir: Su Jin Hong, et al.
Foilsithe / Cruthaithe: (2016-11-01)

EFFICACY OF IBUPROFEN IN TREATMENT OF PAIN IN CHILDREN: SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED STUDIES
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2010-11-01)

EFFICACY OF IBUPROFEN IN TREATMENT OF PAIN IN CHILDREN: SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED STUDIES
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2010-01-01)

Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
de réir: Hyun Lim, et al.
Foilsithe / Cruthaithe: (2025-01-01)

IMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDREN
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-04-01)

DIFFERENTIATED («SEASON») APPROACH TO THE PROPHYLAXIS OF VITAMIN D3 INSUFFICIENCY IN CHILDREN
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2009-09-01)

IMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDREN
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

DIFFERENTIATED («SEASON») APPROACH TO THE PROPHYLAXIS OF VITAMIN D3 INSUFFICIENCY IN CHILDREN
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2009-01-01)

ESOMEPRAZOLE EFFICACY IN TREATMENT OF THE INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT AMONG CHILDREN, SUFFERING FROM RHEUMATIC DISEASES
de réir: E.I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2007-01-01)

ESOMEPRAZOLE EFFICACY IN TREATMENT OF THE INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT AMONG CHILDREN, SUFFERING FROM RHEUMATIC DISEASES
de réir: E.I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2007-01-01)

MICRONUTRIENTS AND CHILDREN'S PHYSICAL GROWTH: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-06-01)

MICRONUTRIENTS AND CHILDREN'S PHYSICAL GROWTH: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

Esomeprazole-induced lichen planus
de réir: Miguel Santos-Coelho, et al.
Foilsithe / Cruthaithe: (2023-04-01)

REGULAR USE OF MILK AND DAIRY PRODUCTS, AND ITS INFLUENCE ON BONE MINERAL DENSITY IN CHILDREN: SYSTEMATIC REVIEW
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-12-01)

REGULAR USE OF MILK AND DAIRY PRODUCTS, AND ITS INFLUENCE ON BONE MINERAL DENSITY IN CHILDREN: SYSTEMATIC REVIEW
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

INCREASE OF BODY WEIGHT IN CHILDREN AS A RESULT OF ADMINISTRATION OF MICRONUTRIENTS CONTAINING VITAMIN A: THE RESULTS OF PLACEBO-CONTROLLED STUDIES
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-10-01)

INCREASE OF BODY WEIGHT IN CHILDREN AS A RESULT OF ADMINISTRATION OF MICRONUTRIENTS CONTAINING VITAMIN A: THE RESULTS OF PLACEBO-CONTROLLED STUDIES
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2008-01-01)

Preclinical Evaluation of Esomeprazole Safety and Toxicokinetics
de réir: V. M. Kosman, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
de réir: David N Roberts, et al.
Foilsithe / Cruthaithe: (2011-03-01)

Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
de réir: Furuta T, et al.
Foilsithe / Cruthaithe: (2012-05-01)

Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study
de réir: Jae Kyun Choi, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
de réir: Jenna Skieneh, et al.
Foilsithe / Cruthaithe: (2016-04-01)

Esomeprazole: a Safe Alternative to Lansoprazole Allergy?
de réir: Muammer Kara, et al.
Foilsithe / Cruthaithe: (2014-08-01)

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats
de réir: Ali Jaber, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Diagnosis and Treatment of Gastroesophageal Reflux Disease in Infants and Children
de réir: Yvan Vandenplas
Foilsithe / Cruthaithe: (2000-01-01)

MELATONIN IN COMPLEX TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN CHILDREN
de réir: O. V. Syresina, et al.
Foilsithe / Cruthaithe: (2012-02-01)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
de réir: Joe S. Smith, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Effect of esomeprazole on lipid profile in patients with peptic ulcer
de réir: Eman Abdullah, et al.
Foilsithe / Cruthaithe: (2021-08-01)

EFFECTIVENESS OF EDITING IN PREPARATION OF ORIGINAL ARTICLES: RESULTS OF RANDOMIZED CONTROLLED STUDY
de réir: R.T. Saygitov
Foilsithe / Cruthaithe: (2010-11-01)